Bioventus (BVS) Other Operating Expenses (2023 - 2025)

Bioventus' (BVS) quarterly Other Operating Expenses came in at $1000.0 in Q3 2025, up 200.0% on a QoQ basis from -$1000.0 in Q2 2025.

Bioventus (BVS) Other Operating Expenses (2023 - 2025) Analysis & Trends

Bioventus (BVS) has 3 years of Other Operating Expenses data on file, last reported at $1000.0 in Q3 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to $1000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$81000.0 (up 72.26% YoY) and the FY2025 annual result came in at -$81000.0, up 72.26% from the prior year.
Other Operating Expenses rose to $1000.0 in Q3 2025, from -$1000.0 in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $1000.0 in Q3 2025 to a low of -$1.4 million in Q3 2023.
A 3-year average of -$564285.7 and a median of -$292000.0 in 2024 frame the typical range for Other Operating Expenses.
The widest YoY moves for Other Operating Expenses: up 75.59% in 2024, down 75.59% in 2024.
Tracing BVS's Other Operating Expenses over 3 years: stood at -$1.2 million in 2023, then soared by 75.59% to -$292000.0 in 2024, then jumped by 100.34% to $1000.0 in 2025.
The last three Other Operating Expenses figures came in at $1000.0 (Q3 2025), -$1000.0 (Q2 2025), and -$81000.0 (Q1 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Bioventus	972.23 Mn	942.77 Mn	105.67 Mn

Download Data